ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

July 12, 2013

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992